Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.399, 2003-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Basiliximab confers significant clinical benefit for marginal cost
Inpharma, Vol. 1, Iss. 1374, 2003-01 ,pp. :
Access to resources
Recommend
Salmeterol/fluticasone propionate confers benefit for minimal cost in asthma
Inpharma, Vol. 1, Iss. 1359, 2002-01 ,pp. :
Salmeterol/fluticasone propionate confers benefit for minimal cost in asthma
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 384, 2002-01 ,pp. :
Intracranial stents − clinical benefit offset by significant costs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 622, 2011-01 ,pp. :
Sertraline: an assessment of clinical benefit and cost in the UK
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :